Sheaff Brock Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,018	Closed	-$30K	–	574
2018 Q2	$30K	Buy	+13,018	New	+$36.3K	﹤0.01%	533
2018 Q1	–	Sell	-16,018	Closed	-$44K	–	598
2017 Q4	$44K	Hold	16,018	–	–	0.01%	521
2017 Q3	$54K	Buy	16,018 +3,000	+23%	+$8.34K	0.01%	553
2017 Q2	$32K	Buy	+13,018	New	+$29.9K	﹤0.01%	594
2017 Q1	–	Sell	-10,563	Closed	-$22K	–	663
2016 Q4	$22K	Buy	+10,563	New	+$29.5K	﹤0.01%	602

Other funds holding PDLI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Sheaff Brock Investment Advisors's PDLI Position: Q3 2018 in Review

Sheaff Brock Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 13,018 shares — an estimated $30K sold.

Sheaff Brock Investment Advisors first reported a position in PDLI in Q4 2016 and held it in 5 quarters. The position peaked at $54K in Q3 2017. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

Sheaff Brock Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 13,018 PDL BioPharma, Inc. shares in Q3 2018, an estimated $30K.
Sheaff Brock Investment Advisors first reported a position in PDL BioPharma, Inc. in Q4 2016 and held it in 5 quarters.
Sheaff Brock Investment Advisors's PDL BioPharma, Inc. position peaked at $54K in Q3 2017.
152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.